Dosing underway in Rhythm Pharma's setmelanotide trial for rare genetic disease of obesity
January 13 2022 - 9:37AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Rhythm Pharmaceuticals (NASDAQ:RYTM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rhythm Pharmaceuticals (NASDAQ:RYTM)
Historical Stock Chart
From Apr 2023 to Apr 2024